LY2148568
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY2148568, covering 2015-02-23 to 2015-02-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes [Phase 2]